Cytokinetics | CYTK - EPS Earnings Per Share

Stock Price
62.42
Daily Change
2.01 3.33%
Monthly
-3.75%
Yearly
44.12%
Q1 Forecast
58.59

Cytokinetics reported $-1.5 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 -1.50 -1.56 -1.26 Feb/24 2026
FY2025Q3 Sep/2025 -2.55 -1.57 -1.36 Nov/05 2025
FY2025Q2 Jun/2025 -1.12 -1.42 -0.08 Aug/07 2025
FY2025Q1 Mar/2025 -1.36 -1.27 -1.33 May/06 2025
FY2024Q4 Dec/2024 -1.26 -1.22 -1.38 Feb/27 2025




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Arca Biopharma USD -0.5 0.08 Mar/2025
Bayer EUR 0.62 0.05 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Brainstorm Cell Therapeutics USD -0.45 0.06 Mar/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Capricor Therapeutics USD -0.53 0.37 Mar/2025
Cytokinetics USD -1.5 1.05 Dec/2025
Eisai JPY 60.94 24.92 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Exelixis USD 0.97 0.19 Dec/2025
Geron USD -0.05 0.02 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025